Literature DB >> 32910135

Error in Text.

.   

Abstract

Year:  2020        PMID： 32910135      PMCID： PMC7489867          DOI： 10.1001/jamaophthalmol.2020.3537

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN： 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  1 in total

1.  Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial.

Authors:  Arshad M Khanani; Sunil S Patel; Philip J Ferrone; Aaron Osborne; Jayashree Sahni; Susanna Grzeschik; Karen Basu; Jason S Ehrlich; Zdenka Haskova; Pravin U Dugel
Journal:  JAMA Ophthalmol       Date:  2020-09-01       Impact factor: 7.389
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.